GAITHERSBURG, Md., March 29, 2023 (GLOBE NEWSWIRE) — Today, Emergent BioSolutions Inc. (NYSE: EBS) announced that the U.S. Food and Drug Administration (FDA) has approved Narcan® Naloxone HCl Nasal Spray 4 mg as an over-the-counter (OTC) emergency treatment of opioid overdose. This decision comes at a time when approximately every eight minutes, a person dies
0 Comments
MIAMI BEACH, Fla., March 28, 2023. Mount Sinai Medical Center (MSMC) is pleased to announce the results of a clinical trial led by Brian Slomovitz, MD, Professor of Obstetrics/Gynecology and Division Director at Mount Sinai Medical Center in Miami Beach, Florida. The investigator-initiated phase II trial, sponsored by the GOG Foundation, investigated the combination of
0 Comments
Enhanced treatment of atopic dermatitis with topical corticosteroids significantly reduced hen’s egg allergy compared with conventional reactive treatment in infants, but also resulted in adverse effects on growth, a randomized controlled trial in Japan showed. Among 640 infants ages 7 to 13 weeks, 31.4% of those who received enhanced treatment to clinically affected and unaffected
0 Comments
Children born to mothers who had COVID-19 during pregnancy may be more likely to develop obesity, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. More than 100 million COVID-19 cases have been reported in the United States since 2019, and there is limited information on the long-term
0 Comments
*Important notice: bioRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information. In a recent study posted to the bioRxiv* preprint server, researchers in the Republic of Korea assessed the efficacy of antiviral medications against novel severe acute respiratory
0 Comments
The New England Journal of Medicine is charging ahead with its coverage of the impact of artificial intelligence (AI) in medicine, publishing a special report, a review, and an editorial in this week’s issue, and announcing the creation of a journal dedicated to AI. The special report, written by researchers from Microsoft, outlined potential medical
0 Comments
The warming of the planet may mean more suicides, new research suggests. New findings show a significant association between higher temperatures and an increase in suicide deaths. These findings “highlight the importance of implementing effective climate policies to reduce greenhouse gas emissions and tailoring public health policies to adapt to global warming,” investigators led by
0 Comments
Image by Allec Gomes @Pexels Epicardial adipose tissue (EAT) is a fancy term for fatty tissue surrounding the heart. Normally, EAT plays an important role in heart function and offers protective factors for good health.1 In abnormal conditions, EAT is a risk factor for cardiometabolic diseases like obesity and insulin resistance.2 Finding a balance of
0 Comments
CARLSBAD, Calif., March 29, 2023. Ionis Pharmaceuticals, Inc. today reported that its partner Biogen presented new Phase 1b clinical data showing that IONIS-MAPTRx (BIIB080) reduced soluble tau protein in cerebrospinal fluid (CSF) in a dose-dependent and sustained manner in patients with early-stage Alzheimer’s disease (AD). IONIS-MAPTRx also reduced aggregated tau pathology, as measured by positron
0 Comments
Sign up for CNN’s Wonder Theory science newsletter. Explore the universe with news on fascinating discoveries, scientific advancements and more. CNN  —  The weather is slowly changing on Jupiter and Uranus, according to our galaxy’s own interplanetary meteorologist. The NASA Hubble Space Telescope captured Earth’s outer planetary neighbors in images from 2014 to 2022, documenting
0 Comments
Cedars-Sinai Guerin Children’s is opening a new plastic surgery program for children with facial deformities. The Cleft and Craniofacial Program, led by Victor Chien, MD, addresses the needs of any pediatric patient with a congenital craniofacial difference, including cleft lip and cleft palate, ear and jaw deformities, skull bones that fuse prematurely, as well as
0 Comments
Individuals with a history of atopic disease, such as asthma and eczema (a.k.a. atopic dermatitis), are at significantly increased risk for developing osteoarthritis (OA), analysis of medical insurance claims indicated. With some 110,000 people with asthma or atopic dermatitis matched to the same number of individuals without these conditions, the odds of developing OA were
0 Comments
Imagine getting the benefits of gastric bypass surgery without going under the knife -; a new class of compounds could do just that. In lab animals, these potential treatments reduce weight dramatically and lower blood glucose. The injectable compounds also avoid the side effects of nausea and vomiting that are common with current weight-loss and
0 Comments
Ozempic and Muscle Loss — Do You Need to Worry? – Diabetes Daily Learning Center Learning Center: LearningCenter Diabetes Daily does not provide medical advice,diagnosis or treatment.Get additional information.© 2005 – 2023 Everyday Health, Inc., a Ziff Davis company. Everyday Health is among the federally registered trademarks of Everyday Health, Inc. and may not be
0 Comments
Since early in the pandemic, physicians have flagged diabetes as a risk factor for worse outcomes with COVID infection, but the relationship may also work the other way: evidence is building that COVID could also be a risk factor for developing diabetes, both type 1 and type 2. While the science isn’t yet settled, and
0 Comments
The US Food and Drug Administration (FDA) has approved over-the-counter sales of the overdose reversal agent Narcan (naloxone, Emergent BioSolutions). Greater access to the drug should mean more lives saved. However, it’s unclear how much the nasal spray will cost and whether pharmacies will stock the product openly on shelves.  Currently, major pharmacy chains such
0 Comments
Used boxes of Mifepristone pills, the first drug used in a medical abortion, fill a trash at Alamo Women’s Clinic in Albuquerque, New Mexico, U.S., January 11, 2023.  Evelyn Hockstein | Reuters Two federal judges are poised to issue rulings soon in dueling cases that could dramatically impact access to the abortion pill mifepristone. In
0 Comments
In this article NOVO.B-DK Follow your favorite stocksCREATE FREE ACCOUNT This photograph taken on February 23, 2023, in Paris, shows the anti-diabetic medication “Ozempic” (semaglutide) made by Danish pharmaceutical company “Novo Nordisk”. Joel Saget | AFP | Getty Images Patients taking blockbuster obesity drugs Ozempic or Wegovy will pack the pounds back on after they
0 Comments